← Open Payments lookup

CATHERINE DEAN: Open Payments

NPI 1780296947 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$895 in 43 payments from 24 companies in 2025. Trend: 2023 $682 · 2024 $941 · 2025 $895

Food & beverage: $895
CompanyPaymentsAmount
Aimmune Therapeutics, Inc.6$106
SHIELD THERAPEUTICS INC2$90
Takeda Pharmaceuticals U.S.A., Inc.4$84
GENZYME CORPORATION4$83
AstraZeneca Pharmaceuticals LP4$74
QOL Medical, LLC2$65
Novartis Pharmaceuticals Corporation2$53
Merck Sharp & Dohme LLC2$45
Janssen Biotech, Inc.2$32
Incyte Corporation1$25

Products named: ACCRUFER, Sucraid, DUPIXENT, ZENPEP, VOWST, KEYTRUDA, ENTYVIO, TREMFYA.

Industry payments across OK — which companies pay providers there.